# Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.

> **NCT00432263** · PHASE4 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Brain Injuries

## Interventions

- **DRUG:** Genotropin (PN-180,307) Somatropin

## Key facts

- **NCT ID:** NCT00432263
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432263, "Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00432263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*